Table 1 |
|||||||
|
Susceptibility levels of S.pneumoniae isolates |
|||||||
|
S. pneumoniae |
MIC (μg/ml) |
||||||
|
strain |
PG |
CT |
EM |
CI |
KM |
TC |
LZ |
|
|
|||||||
|
R6-WT |
0.023 |
0.023 |
0.125 |
0.5 |
25 |
0.125 |
0.38 |
|
R6M1 |
2.0 |
0.75 |
0.125 |
0.5 |
25 |
0.125 |
0.38 |
|
R6M2 |
2.0 |
0.75 |
0.125 |
0.5 |
25 |
0.125 |
0.38 |
|
1974-WT |
0.016 |
0.023 |
0.125 |
0.5 |
25 |
0.125 |
0.75 |
|
1974M1 |
2.0 |
1.5 |
0.125 |
0.5 |
25 |
0.125 |
0.75 |
|
1974M2 |
2.0 |
2.0 |
0.125 |
0.5 |
25 |
0.125 |
0.75 |
|
|
|||||||
|
Results are the average of at least three independent measurements. CI, ciprofloxacin; CT, cefotaxime; EM, erythromycin; KM, kanamycin; LZ, linezolid; PG, penicillin G; TC, tetracycline; WT, wild-type. |
|||||||
|
Fani et al. Genome Biology 2011 12:R115 doi:10.1186/gb-2011-12-11-r115 |
|||||||
